These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35291010)

  • 1. Rapid Decline of Ceftazidime Resistance in Antibiotic-Free and Sublethal Environments Is Contingent on Genetic Background.
    Hernando-Amado S; Laborda P; Valverde JR; Martínez JL
    Mol Biol Evol; 2022 Mar; 39(3):. PubMed ID: 35291010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and robust evolution of collateral sensitivity in
    Hernando-Amado S; Sanz-García F; Martínez JL
    Sci Adv; 2020 Aug; 6(32):eaba5493. PubMed ID: 32821825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Habitat-Dependent Antibiotic Resistance in Pseudomonas aeruginosa.
    Laborda P; Martínez JL; Hernando-Amado S
    Microbiol Spectr; 2022 Aug; 10(4):e0024722. PubMed ID: 35766499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolutionary reversals of antibiotic resistance in experimental populations of Pseudomonas aeruginosa.
    Gifford DR; MacLean RC
    Evolution; 2013 Oct; 67(10):2973-81. PubMed ID: 24094347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC.
    Cabot G; Bruchmann S; Mulet X; Zamorano L; Moyà B; Juan C; Haussler S; Oliver A
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3091-9. PubMed ID: 24637685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro.
    Henrichfreise B; Wiegand I; Luhmer-Becker I; Wiedemann B
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3642-9. PubMed ID: 17682103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative Evolutionary Paths to Bacterial Antibiotic Resistance Cause Distinct Collateral Effects.
    Barbosa C; Trebosc V; Kemmer C; Rosenstiel P; Beardmore R; Schulenburg H; Jansen G
    Mol Biol Evol; 2017 Sep; 34(9):2229-2244. PubMed ID: 28541480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa.
    Qi Q; Toll-Riera M; Heilbron K; Preston GM; MacLean RC
    Proc Biol Sci; 2016 Jan; 283(1822):. PubMed ID: 26763710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant
    Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; Martínez JL
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrolysis of cefazolin by enzymes produced by Pseudomonas aeruginosa after exposure to ceftazidime in vitro.
    Papaioannidou P; Nitsas V; Mirtsou-Fidani V
    Vojnosanit Pregl; 2009 Oct; 66(10):785-90. PubMed ID: 19938755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients.
    Zamudio R; Hijazi K; Joshi C; Aitken E; Oggioni MR; Gould IM
    Int J Antimicrob Agents; 2019 Jun; 53(6):774-780. PubMed ID: 30831233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorhexidine leads to the evolution of antibiotic-resistant Pseudomonas aeruginosa.
    Tag ElDein MA; Yassin AS; El-Tayeb O; Kashef MT
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2349-2361. PubMed ID: 34169445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitals.
    Castanheira M; Doyle TB; Smith CJ; Mendes RE; Sader HS
    J Antimicrob Chemother; 2019 Sep; 74(9):2588-2595. PubMed ID: 31225882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation-Driven Evolution of Pseudomonas aeruginosa in the Presence of either Ceftazidime or Ceftazidime-Avibactam.
    Sanz-García F; Hernando-Amado S; Martínez JL
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of biofilm formation and antibiotic resistance pattern of Pseudomonas aeruginosa in human and environmental isolates.
    Gholami S; Tabatabaei M; Sohrabi N
    Microb Pathog; 2017 Aug; 109():94-98. PubMed ID: 28549926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary landscapes of Pseudomonas aeruginosa towards ribosome-targeting antibiotic resistance depend on selection strength.
    Sanz-García F; Sánchez MB; Hernando-Amado S; Martínez JL
    Int J Antimicrob Agents; 2020 Jun; 55(6):105965. PubMed ID: 32325206
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Karlowsky JA; Kazmierczak KM; Bouchillon SK; de Jonge BLM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and phenotypic comparison of environmental and patient-derived isolates of
    Ramsay KA; Wardell SJT; Patrick WM; Brockway B; Reid DW; Winstanley C; Bell SC; Lamont IL
    J Med Microbiol; 2019 Nov; 68(11):1591-1595. PubMed ID: 31553303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying and exploiting genes that potentiate the evolution of antibiotic resistance.
    Gifford DR; Furió V; Papkou A; Vogwill T; Oliver A; MacLean RC
    Nat Ecol Evol; 2018 Jun; 2(6):1033-1039. PubMed ID: 29686236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.